Literature DB >> 18640746

Synthesis of modified pyrimidine bases and positive impact of chemically reactive substituents on their in vitro antiproliferative activity.

Steffi Noll1, Marijeta Kralj, Lidija Suman, Holger Stephan, Ivo Piantanida.   

Abstract

The antiproliferative activity screening on human tumor cell lines of a series of modified uracil and cytosine bases as well as some corresponding acyclonucleosides, and comparison of structure-activity relationship revealed the importance of chemical reactivity of the substituent attached to the C5-position of uracil for the activity of studied compounds. Namely, the results obtained for the most active compounds, 5-(chloroacetylamino)uracil (2) and its acyclic sugar analogue 18, suggest that formation of a covalent bond between reactive substituent and several possible targets within the thymidylate synthase mechanism (sulphur of the cysteine residue, basic part of the enzyme, N,N-methylene tetrahydrofolate or its reactive iminium forms) is the most probable mode of action. In addition, novel C5-substituted uracil derivative 6 (5-[bis-(2-p-methoxybenzylthioethyl)amine]acetylaminouracil) exhibited high antiproliferative activity against HeLa and MiaPaCa-2 cell lines, by an as yet unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640746     DOI: 10.1016/j.ejmech.2008.06.002

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

Review 1.  Synthesis, reactivity, and biological activity of 5-aminouracil and its derivatives.

Authors:  Raafat Mohamed Shaker; Mohamed Abd Elrady; Kamal Usef Sadek
Journal:  Mol Divers       Date:  2015-04-30       Impact factor: 2.943

2.  Synthesis of C-Pseudonucleosides Bearing Thiazolidin-4-one as a Novel Potential Immunostimulating Agent.

Authors:  Hua Chen; Qingmei Yin; Chunxiao Li; Enkai Wang; Fang Gao; Xiaobo Zhang; Zhi Yin; Sinan Wei; Xiaoliu Li; Ming Meng; Pingzhu Zhang; Na Li; Jinchao Zhang
Journal:  ACS Med Chem Lett       Date:  2011-09-07       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.